Roy Navon
Impact in
-
- Antibiotic Use and Resistance
- Cancer Research top 2%
- MicroRNA in disease regulation
Papers in
- Epidemiology 17
- Sepsis Diagnosis and Treatment 15
- Pneumonia and Respiratory Infections 3
-
- MicroRNA in disease regulation 5
- Co-authors
- Zohar Yakhini B (10 shared papers)Israel Steinfeld (7 shared papers)Eran Eden (10 shared papers)Doron Lipson (2 shared papers)Anya Tsalenko (2 shared papers)Amir Ben‐Dor (1 shared paper)Hui Wang (1 shared paper)Anne‐Lise Børresen‐Dale (2 shared papers)
- Journals
- PLoS ONE (7 papers)Open Forum Infectious Diseases (4 papers)BMC Bioinformatics (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Clinical Microbiology and Infection (2 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Roy Navon
29 papers receiving 4k citations
Roy Navon's Hit Papers
Peers
Comparison fields: 5 of 123
- Applied Microbiology and Biotechnology 114
- Cancer Research 633
- Aging 61
- Molecular Biology 1.5k
- Epidemiology 523
Countries citing papers authored by Roy Navon
This map shows the geographic impact of Roy Navon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Navon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Navon more than expected).
Fields of papers citing papers by Roy Navon
This network shows the impact of papers produced by Roy Navon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Navon. The network helps show where Roy Navon may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy Navon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists Hit paper breakdown → | 2009 | 2611 |
| 2 | 2011 | 266 | |
| 3 | 2015 | 189 | |
| 4 | 2009 | 150 | |
| 5 | 2012 | 121 | |
| 6 | 2017 | 94 | |
| 7 | 2019 | 90 | |
| 8 | 2018 | 73 | |
| 9 | 2021 | 64 | |
| 10 | 2010 | 55 | |
| 11 | 2012 | 46 | |
| 12 | 2016 | 42 | |
| 13 | 2021 | 42 | |
| 14 | 2017 | 36 | |
| 15 | 2011 | 28 | |
| 16 | 2022 | 21 | |
| 17 | 2008 | 16 | |
| 18 | 2023 | 14 | |
| 19 | 2015 | 11 | |
| 20 | 2021 | 11 |
About Roy Navon
Roy Navon is a scholar working on Epidemiology, Cancer Research, Applied Microbiology and Biotechnology, Immunology and Infectious Diseases, having authored 32 papers that have together received 4k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (15 papers), MicroRNA in disease regulation (5 papers), Inflammation biomarkers and pathways (5 papers), COVID-19 Clinical Research Studies (3 papers), Pneumonia and Respiratory Infections (3 papers), Gene expression and cancer classification (3 papers), Antibiotic Use and Resistance (3 papers) and Clinical Laboratory Practices and Quality Control (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (114 citations), Cancer Research (633 citations), Aging (61 citations), Molecular Biology (1.5k citations) and Epidemiology (523 citations). Roy Navon has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Zohar Yakhini B, Israel Steinfeld, Eran Eden, Doron Lipson, Anya Tsalenko, Amir Ben‐Dor, Hui Wang, Anne‐Lise Børresen‐Dale, Espen Enerly and Hege Giercksky Russnes. Their work appears in journals such as PLoS ONE, Open Forum Infectious Diseases, BMC Bioinformatics, European Journal of Clinical Microbiology & Infectious Diseases and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.